购物车
- 全部删除
- 您的购物车当前为空
CH-0793076, a hexacyclic camptothecin analog, is an active drug and major metabolite of TP300. CH-0793076 is efficacious against cells expressing BCRP (breast cancer resistance protein). CH-0793076 inhibits DNA topoisomerase I (IC50: 2.3 μM).
CH-0793076, a hexacyclic camptothecin analog, is an active drug and major metabolite of TP300. CH-0793076 is efficacious against cells expressing BCRP (breast cancer resistance protein). CH-0793076 inhibits DNA topoisomerase I (IC50: 2.3 μM).
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
100 mg | 询价 | 期货 | |
500 mg | 询价 | 期货 |
产品描述 | CH-0793076, a hexacyclic camptothecin analog, is an active drug and major metabolite of TP300. CH-0793076 is efficacious against cells expressing BCRP (breast cancer resistance protein). CH-0793076 inhibits DNA topoisomerase I (IC50: 2.3 μM). |
靶点活性 | Topo I:2.3 μM |
体外活性 | CH0793076 (6 days at 37°C) displays antiproliferative activity against PC-6/BCRP and PC-6/pRC cells (IC50: 0.35 and 0.18 nM). |
体内活性 | TP300 (1-100 mg/kg; bolus intravenous injection once per week for 3 weeks, for a total of three doses) demonstrates over 50% tumor growth inhibition across all nine models. |
别名 | TP3076 |
分子量 | 458.51 |
分子式 | C26H26N4O4 |
CAS No. | 534605-78-2 |
密度 | 1.46 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容